搜索医学 AI 论文与资源

ICLR 2026 Poster accepted paper at ICLR 2026. Fusing histopathology images and genomics data with deep learning has significantly advanced precision oncology. However, genomics data is often missing due to its high acquisition cost and complexity in real-world clinical scenarios. Existing solutions aim to reconstruct genomics data from histopathology images. Nevertheless, these methods typically relied only on individual case and overlooked the potential relationships among cases. Additionally, they failed to take advantage of the authentic genomics data of diagnostically related cases that are accessible from training for inference. In this work, we propose a novel Multi-modal Structural Representation Learning (MSRL) framework for data-efficient precision oncology. Code/project link: https://github.com/WkEEn/MSRL

ICLR 2026 Poster accepted paper at ICLR 2026. Cancer patients are increasingly turning to large language models (LLMs) for medical information, making it critical to assess how well these models handle complex, personalized questions. However, current medical benchmarks focus on medical exams or consumer-searched questions and do not evaluate LLMs on real patient questions with patient details. In this paper, we first have three hematology-oncology physicians evaluate cancer-related questions drawn from real patients. While LLM responses are generally accurate, the models frequently fail to recognize or address false presuppositions} in the questions, posing risks to safe medical decision-making.

The Cancer Genome Atlas is a large cancer genomics resource with molecular, clinical, and pathology-related data across many cancer types. It is a foundation dataset for oncology AI, survival prediction, subtype discovery, multimodal cancer modeling, and translational biomarker research.

Grand Challenge official API lists this medical AI challenge with status OPEN_SOON. HEad and neCK TumOR Lesion Segmentation, Staging and Prognosis Start date: 2026-05-31. End/deadline date: 2026-07-24.

This Nature Portfolio / npj Gut and Liver collection is open for submissions until 2026-05-12. It welcomes work on risk assessment and early detection of gastrointestinal and liver cancers, including artificial intelligence tools for cancer risk assessment, early-stage detection, novel imaging, tissue acquisition modalities, and health economics for screening.

This Nature Portfolio / npj Genomic Medicine collection is open for submissions until 2026-06-23. It covers AI-powered genomic medicine, including variant prioritization, pathway inference, AI prediction from clinical assays such as histology, radiology and EHRs, multi-omics, precision oncology, rare diseases, population health, explainability, bias, and clinical implementation.